Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17124214 | METHODS, PROBE SETS, AND KITS FOR DETECTION OF DELETION OF TUMOR SUPPRESSOR GENES BY FLUORESCENCE IN SITU HYBRIDIZATION | December 2020 | January 2024 | Abandon | 37 | 1 | 1 | No | No |
| 17059927 | NUCLEIC ACID DETECTION METHOD | November 2020 | March 2024 | Abandon | 39 | 6 | 0 | Yes | No |
| 17086203 | FAST-FORWARD SEQUENCING BY SYNTHESIS METHODS | October 2020 | January 2023 | Abandon | 27 | 3 | 0 | Yes | Yes |
| 17037594 | PROGRAMMABLE NUCLEASE COMPOSITIONS AND METHODS OF USE THEREOF | September 2020 | April 2023 | Allow | 31 | 4 | 0 | Yes | Yes |
| 17025763 | METHODS AND SYSTEMS FOR REDUCING PHASING ERRORS WHEN SEQUENCING NUCLEIC ACIDS USING TERMINATION CHEMISTRY | September 2020 | February 2024 | Abandon | 41 | 2 | 0 | Yes | No |
| 16963063 | METHYLATION MARKERS FOR MELANOMA AND USES THEREOF | July 2020 | August 2024 | Abandon | 53 | 2 | 0 | No | No |
| 16960138 | METHOD AND SYSTEM FOR SUPERCOILING DNA | July 2020 | May 2023 | Abandon | 34 | 4 | 0 | Yes | No |
| 16916305 | APTAMER METHOD | June 2020 | February 2023 | Allow | 31 | 1 | 0 | No | No |
| 16957400 | METHOD OF COLLECTING NUCLEIC ACID | June 2020 | March 2023 | Allow | 33 | 2 | 0 | Yes | No |
| 16880706 | METHODS OF ATTACHING ADAPTERS TO SAMPLE NUCLEIC ACIDS | May 2020 | May 2023 | Abandon | 35 | 2 | 0 | Yes | Yes |
| 16879214 | MOLECULAR TAGGING SYSTEM WITH NANOPORE-ORTHOGONAL DNA BARCODES | May 2020 | August 2023 | Abandon | 39 | 1 | 1 | Yes | No |
| 16877964 | METHODS AND SYSTEMS FOR PROCESSING NUCLEIC ACID MOLECULES | May 2020 | August 2023 | Abandon | 39 | 2 | 0 | No | No |
| 16876709 | METHOD FOR TRANSPOSASE-MEDIATED SPATIAL TAGGING AND ANALYZING GENOMIC DNA IN A BIOLOGICAL SAMPLE | May 2020 | February 2023 | Abandon | 33 | 4 | 0 | Yes | No |
| 16876682 | METHOD FOR TRANSPOSASE-MEDIATED SPATIAL TAGGING AND ANALYZING GENOMIC DNA IN A BIOLOGICAL SAMPLE | May 2020 | January 2023 | Abandon | 32 | 4 | 0 | Yes | Yes |
| 16864971 | FAST-FORWARD SEQUENCING BY SYNTHESIS METHODS | May 2020 | April 2023 | Abandon | 35 | 0 | 1 | No | No |
| 16857005 | CANCER ANTIGEN-SPECIFIC T-CELL RECEPTOR GENE, PEPTIDE ENCODED BY THE GENE, AND USE OF THEM | April 2020 | January 2023 | Abandon | 33 | 0 | 1 | No | No |
| 16851009 | METHOD FOR VERIFYING BIOASSAY SAMPLES | April 2020 | October 2023 | Abandon | 42 | 2 | 1 | No | No |
| 16651932 | RAPID IN SITU DETECTION OF DNA AND RNA | March 2020 | May 2024 | Abandon | 50 | 4 | 0 | Yes | No |
| 16826035 | BIOCHEMICALLY ACTIVATED ELECTRONIC DEVICE | March 2020 | September 2023 | Abandon | 42 | 2 | 0 | Yes | No |
| 16822012 | IDED DOUBLE-STRANDED PROBES FOR DETECTION OF NUCLEIC ACID AND USES OF SAME | March 2020 | September 2023 | Abandon | 42 | 1 | 1 | No | No |
| 16820255 | THERMAL CALIBRATION | March 2020 | October 2023 | Abandon | 43 | 2 | 0 | No | No |
| 16798704 | LABELING METHOD FOR NUCLEIC ACID | February 2020 | August 2022 | Allow | 30 | 1 | 0 | No | No |
| 16781409 | TRIMETHYLAMINE COMPOUNDS AS RISK PREDICTORS OF CARDIOVASCULAR DISEASE | February 2020 | March 2024 | Allow | 50 | 1 | 0 | Yes | No |
| 16720205 | Gradient Structures Interfacing Microfluidics and Nanofluidics, Methods for Fabrication and Uses Thereof | December 2019 | January 2023 | Abandon | 37 | 1 | 0 | No | No |
| 16701119 | ULTRA SENSITIVE PROBES FOR DETECTION OF NUCLEIC ACID | December 2019 | June 2024 | Abandon | 54 | 3 | 0 | No | No |
| 16593316 | NEUROFIBROMIN/DOPAMINE SIGNALING AS A BIOMARKER FOR COGNITIVE AND BEHAVIORAL PROBLEMS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1) | October 2019 | April 2021 | Allow | 18 | 1 | 0 | No | No |
| 16553843 | PLATFORM INDEPENDENT HAPLOTYPE IDENTIFICATION AND USE IN ULTRASENSITIVE DNA DETECTION | August 2019 | August 2023 | Abandon | 48 | 2 | 0 | No | No |
| 16528760 | ENZYME- AND AMPLIFICATION-FREE SEQUENCING | August 2019 | March 2023 | Abandon | 43 | 1 | 1 | No | No |
| 16478078 | METHODS FOR HAPLOTYPE AND DIPLOTYPE DETERMINATION | July 2019 | September 2023 | Abandon | 50 | 2 | 0 | No | No |
| 16423657 | REAGENTS AND METHODS FOR POST-SYNTHETIC MODIFICATION OF NUCLEIC ACIDS | May 2019 | February 2022 | Allow | 33 | 1 | 0 | Yes | No |
| 16421407 | FECAL SAMPLE PROCESSING AND ANALYSIS COMPRISING DETECTION OF BLOOD | May 2019 | March 2023 | Abandon | 46 | 2 | 0 | No | No |
| 16417109 | METHODS FOR DETECTING TARGET NUCLEIC ACIDS IN A SAMPLE | May 2019 | March 2022 | Abandon | 34 | 0 | 1 | No | No |
| 16415617 | TARGETED NON-INVASIVE PRENATAL TESTING | May 2019 | January 2023 | Abandon | 44 | 2 | 0 | No | No |
| 16382532 | METHOD FOR DETECTING TARGET NUCLEIC ACID MOLECULE | April 2019 | March 2023 | Abandon | 47 | 2 | 1 | No | No |
| 16378104 | METHODS AND COMPOSITIONS FOR ANALYZING NUCLEIC ACID | April 2019 | April 2020 | Abandon | 12 | 1 | 0 | No | No |
| 16362407 | METHODS AND SYSTEMS FOR REDUCING PHASING ERRORS WHEN SEQUENCING NUCLEIC ACIDS USING TERMINATION CHEMISTRY | March 2019 | November 2020 | Abandon | 20 | 1 | 0 | No | No |
| 16358185 | SYSTEMS AND METHODS FOR NUCLEIC ACID SEQUENCING | March 2019 | March 2023 | Abandon | 47 | 3 | 0 | No | No |
| 16328039 | METHOD FOR DETECTING MICROORGANISMS IN A SAMPLE | February 2019 | November 2022 | Abandon | 44 | 4 | 0 | No | No |
| 16324836 | COMPOSITIONS AND METHODS FOR ANALYZING NUCLEIC ACIDS ASSOCIATED WITH AN ANALYTE | February 2019 | October 2022 | Abandon | 45 | 1 | 0 | No | No |
| 16263726 | METHODS FOR REMOVAL OF ADAPTOR DIMERS FROM NUCLEIC ACID SEQUENCING PREPARATIONS | January 2019 | October 2022 | Allow | 44 | 2 | 1 | Yes | No |
| 16263074 | REDUCTION OF SIGNAL FROM CONTAMINANT NUCLEIC ACIDS | January 2019 | July 2024 | Abandon | 60 | 6 | 0 | Yes | No |
| 16320325 | DNA PROBES FOR IN SITU HYBRIDIZATION ON CHROMOSOMES | January 2019 | November 2023 | Abandon | 58 | 1 | 0 | No | No |
| 16253715 | METHODS AND COMPOSITIONS FOR DISCRETE MELT ANALYSIS | January 2019 | March 2022 | Allow | 38 | 1 | 0 | No | No |
| 16319499 | METHODS AND KITS FOR ANALYZING DNA BINDING MOIETIES ATTACHED TO DNA | January 2019 | June 2021 | Abandon | 28 | 1 | 0 | No | No |
| 16244049 | ENHANCED METHODS OF RIBONUCLEIC ACID HYBRIDIZATION | January 2019 | February 2024 | Abandon | 60 | 5 | 0 | Yes | No |
| 16236599 | COMPARATIVE GENOMIC HYBRIDIZATION ON ENCODED MULTIPLEX PARTICLES | December 2018 | September 2022 | Abandon | 44 | 2 | 0 | No | Yes |
| 16227790 | DETECTION AND QUANTIFICATION OF RARE VARIANTS WITH LOW-DEPTH SEQUENCING VIA SELECTIVE ALLELE ENRICHMENT OR DEPLETION | December 2018 | May 2022 | Abandon | 40 | 2 | 0 | Yes | No |
| 16302346 | METHOD FOR DETECTION OF A PCR PRODUCT | November 2018 | July 2023 | Abandon | 56 | 6 | 0 | Yes | No |
| 16165408 | DIAGNOSIS OF VIRAL INFECTIONS BY DETECTION OF GENOMIC AND INFECTIOUS VIRAL DNA BY MOLECULAR COMBING | October 2018 | November 2022 | Abandon | 49 | 2 | 1 | No | No |
| 16093916 | METHODS FOR EARLY DETECTION OF CANCER | October 2018 | January 2022 | Abandon | 39 | 1 | 1 | No | No |
| 16160820 | USE OF TRANSLATIONAL PROFILING TO IDENTIFY TARGET MOLECULES FOR THERAPEUTIC TREATMENT | October 2018 | January 2022 | Abandon | 39 | 2 | 0 | No | No |
| 16093636 | SYSTEMS AND METHODS FOR DETECTING GENETIC ALTERATIONS | October 2018 | February 2023 | Allow | 52 | 2 | 1 | No | No |
| 16092820 | METHODS OF PREDICTING PREECLAMPSIA USING BIOMARKERS | October 2018 | January 2022 | Allow | 40 | 2 | 1 | No | No |
| 16152378 | NUCLEIC ACID SAMPLE PREPARATION METHODS | October 2018 | June 2021 | Allow | 33 | 3 | 0 | No | No |
| 16089496 | SURFACE-BASED DETECTION OF NUCLEIC ACID IN A CONVECTION FLOW FLUIDIC DEVICE | September 2018 | August 2023 | Abandon | 59 | 3 | 1 | No | No |
| 16086908 | USE OF AN AQUEOUS COMPOSITION FOR DISSOLVING BIOMOLECULES FROM A TISSUE SAMPLE | September 2018 | September 2023 | Abandon | 60 | 9 | 0 | Yes | No |
| 16075709 | METHOD FOR DETECTING TARGET NUCLEIC ACID AND NUCLEIC ACID PROBE USED THEREIN | August 2018 | April 2022 | Allow | 44 | 2 | 0 | Yes | No |
| 16052538 | METHODS AND SYSTEMS THAT DETECT NUCLEIC-ACID TARGETS | August 2018 | January 2024 | Allow | 60 | 2 | 0 | Yes | Yes |
| 16048695 | SOLUTION FOR EXTRACTION OF RNA | July 2018 | April 2023 | Allow | 57 | 2 | 0 | Yes | Yes |
| 16048196 | NOVEL ADAPTOR FOR NUCLEIC ACID SEQUENCING AND METHOD OF USE | July 2018 | March 2023 | Abandon | 56 | 3 | 1 | No | No |
| 16073210 | METHOD FOR DECODING BASE SEQUENCE OF NUCLEIC ACID CORRESPONDING TO END REGION OF RNA AND METHOD FOR ANALYZING DNA ELEMENT | July 2018 | February 2022 | Allow | 42 | 2 | 0 | No | No |
| 16071977 | TARGET ANALYSIS METHOD AND TARGET ANALYSIS KIT FOR USE IN THE METHOD | July 2018 | February 2021 | Abandon | 31 | 1 | 0 | No | No |
| 16071529 | Target Analysis Method and Target Analyzing Chip | July 2018 | February 2021 | Abandon | 31 | 1 | 0 | No | No |
| 15756944 | METHOD OF ISOLATING NUCLEIC ACID | July 2018 | November 2022 | Abandon | 56 | 4 | 0 | Yes | No |
| 16070678 | METHOD OF DIRECT TARGET SEQUENCING USING NUCLEASE PROTECTION | July 2018 | May 2024 | Allow | 60 | 3 | 0 | Yes | Yes |
| 15756195 | COMPOSITION AND METHODS FOR DETECTING ADENOSINE MODIFICATIONS | July 2018 | March 2022 | Allow | 49 | 3 | 0 | Yes | No |
| 16023051 | METHODS OF SYNTHESIZING AND LABELING NUCLEIC ACID MOLECULES | June 2018 | February 2021 | Abandon | 32 | 3 | 0 | No | No |
| 16016086 | COMPOSITIONS AND METHODS FOR DETECTING VIRAL NUCLEIC ACIDS | June 2018 | July 2021 | Abandon | 37 | 2 | 0 | No | No |
| 16062639 | USE OF ANTISENSE LONG NON-CODING RNAS FOR THE DIAGNOSIS OF PROSTATE CANCER | June 2018 | October 2022 | Abandon | 52 | 3 | 1 | Yes | No |
| 15985282 | CHEMICAL LIGATION DEPENDENT PROBE AMPLIFICATION (CLPA) | May 2018 | May 2024 | Abandon | 60 | 2 | 0 | Yes | Yes |
| 15978333 | Strain Typing Assay and Method Without Need for Isolation in Pure Form and Subsequent Longitudinal Strain Tracking | May 2018 | October 2021 | Abandon | 41 | 4 | 0 | Yes | No |
| 15775393 | METHODS AND KITS FOR NUCLEIC ACID DETECTION | May 2018 | January 2022 | Abandon | 44 | 2 | 0 | No | No |
| 15972331 | OLIGONUCLEOTIDE DETECTION METHOD | May 2018 | September 2020 | Abandon | 29 | 4 | 0 | No | Yes |
| 15953316 | METHODS OF ATTACHING ADAPTERS TO SAMPLE NUCLEIC ACIDS | April 2018 | April 2022 | Allow | 48 | 2 | 0 | No | Yes |
| 15920421 | METHODS OF DEPLETING OR ISOLATING TARGET RNA FROM A NUCLEIC ACID SAMPLE | March 2018 | June 2020 | Abandon | 27 | 1 | 1 | No | No |
| 15891316 | Methods and Compositions For Sorting and/or Determining Organisms | February 2018 | January 2022 | Abandon | 47 | 2 | 0 | No | No |
| 15888042 | Methods, Compositions and Kits for Detection of Mutant Variants of Target Genes | February 2018 | November 2021 | Abandon | 45 | 2 | 1 | Yes | No |
| 15747130 | NUCLEIC ACID DETECTION METHOD | January 2018 | March 2022 | Allow | 50 | 3 | 0 | No | Yes |
| 15875385 | METHOD OF DETERMINING TARGET NUCLEIC ACID | January 2018 | February 2023 | Allow | 60 | 4 | 1 | Yes | No |
| 15746395 | LOCKED NUCLEIC ACIDS FOR CAPTURING FUSION GENES | January 2018 | March 2022 | Abandon | 50 | 2 | 0 | No | No |
| 15746371 | SEQUENCE-INDEPENDENT NUCLEIC ACID ASSEMBLY | January 2018 | April 2021 | Abandon | 39 | 2 | 0 | Yes | No |
| 15746328 | SYSTEMS AND METHODS OF GENETIC ANALYSIS | January 2018 | November 2021 | Abandon | 45 | 2 | 0 | No | No |
| 15869831 | METHOD OF UTILIZING ENZYME FOR ISOTHERMAL NUCLEIC ACID HYBRIDIZATION | January 2018 | March 2020 | Abandon | 27 | 1 | 0 | No | No |
| 15555054 | SIGNATURE OF HEALTH | December 2017 | March 2022 | Abandon | 54 | 5 | 1 | Yes | Yes |
| 15739301 | SELECTIVE DEGRADATION OF WILD-TYPE DNA AND ENRICHMENT OF MUTANT ALLELES USING NUCLEASE | December 2017 | March 2023 | Allow | 60 | 3 | 1 | Yes | No |
| 15739354 | BRANCHED PROXIMITY HYBRIDIZATION ASSAY | December 2017 | January 2022 | Abandon | 49 | 2 | 0 | No | No |
| 15738982 | COMPOSITIONS AND METHODS FOR ANALYTE DETECTION USING NANOSWITCHES | December 2017 | April 2024 | Allow | 60 | 7 | 1 | No | No |
| 15840871 | GENOME CAPTURE AND SEQUENCING FOR COMPREHENSIVE CHROMATIN STRUCTURE MAPS IN COMPLEX GENOMES AND CANCER PROGRESSION | December 2017 | November 2020 | Allow | 35 | 1 | 0 | Yes | No |
| 15839795 | BIOCHEMICALLY ACTIVATED ELECTRONIC DEVICE | December 2017 | September 2019 | Allow | 21 | 3 | 0 | Yes | Yes |
| 15578821 | NUCLEIC ACID DETECTION | December 2017 | January 2020 | Abandon | 25 | 1 | 0 | No | No |
| 15579071 | IMPROVEMENTS IN AND RELATING TO NUCLEIC ACID PROBES AND HYBRIDISATION METHODS | December 2017 | August 2023 | Abandon | 60 | 6 | 1 | Yes | No |
| 15826035 | METHOD FOR OPTIMAL DESIGN OF POLYNUCLEOTIDES SEQUENCES FOR ANALYSIS OF SPECIFIC EVENTS IN ANY GENETIC REGION OF INTEREST | November 2017 | February 2020 | Abandon | 26 | 2 | 0 | No | No |
| 15824641 | OSTEOPOROSIS ASSOCIATED MARKERS AND METHODS OF USE | November 2017 | November 2019 | Abandon | 23 | 1 | 0 | No | No |
| 15820798 | Method for Detecting Target Nucleic Acid | November 2017 | January 2019 | Abandon | 13 | 1 | 1 | No | No |
| 15573131 | ULTRA SENSITIVE PROBES FOR DETECTION OF NUCLEIC ACID | November 2017 | January 2020 | Abandon | 26 | 1 | 0 | Yes | No |
| 15800291 | Methods of Hybridizing Probes to Genomic DNA | November 2017 | June 2020 | Abandon | 31 | 1 | 0 | Yes | No |
| 15784855 | STOICHIOMETRIC TUNING OF NUCLEIC ACID HYBRIDIZATION PROBES BY AUXILIARY OLIGONUCLEOTIDE SPECIES | October 2017 | May 2021 | Abandon | 43 | 5 | 0 | Yes | Yes |
| 15729421 | COMPOSITIONS AND METHODS FOR THE DETECTION OF GENOMIC FEATURES | October 2017 | June 2020 | Abandon | 32 | 1 | 1 | No | No |
| 15724479 | METHODS AND SYSTEMS FOR DETECTING A NUCLEIC ACID IN A SAMPLE BY ANALYZING HYBRIDIZATION | October 2017 | August 2020 | Abandon | 34 | 3 | 0 | Yes | No |
| 15559827 | IDED DOUBLE-STRANDED PROBES FOR DETECTION OF NUCLEIC ACID AND USES OF SAME | September 2017 | March 2020 | Abandon | 30 | 1 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SISSON, BRADLEY L.
With a 47.9% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 20.2% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner SISSON, BRADLEY L works in Art Unit 1634 and has examined 816 patent applications in our dataset. With an allowance rate of 16.9%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 42 months.
Examiner SISSON, BRADLEY L's allowance rate of 16.9% places them in the 2% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by SISSON, BRADLEY L receive 2.76 office actions before reaching final disposition. This places the examiner in the 77% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by SISSON, BRADLEY L is 42 months. This places the examiner in the 18% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +18.1% benefit to allowance rate for applications examined by SISSON, BRADLEY L. This interview benefit is in the 59% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 3.7% of applications are subsequently allowed. This success rate is in the 2% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 8.8% of cases where such amendments are filed. This entry rate is in the 10% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 70.4% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 59% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 63.4% of appeals filed. This is in the 42% percentile among all examiners. Of these withdrawals, 38.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 83.7% are granted (fully or in part). This grant rate is in the 86% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 2.9% of allowed cases (in the 80% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 1.4% of allowed cases (in the 67% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.